SS
BBNX

Steve Schonfeld’s Beta Bionics BBNX Stock Holding History

Steve Schonfeld’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-59,624
Closed -$597K – 3115
2026
Q1 		$597K Buy
+59,624
New +$882K ﹤0.01% 1309
2025
Q4 		– Sell
-183,663
Closed -$3.65M – 2729
2025
Q3 		$3.65M Buy
183,663
+113,488
+162% +$1.99M 0.02% 738
2025
Q2 		$1.02M Sell
70,175
-67,147
-49% -$951K 0.01% 1297
2025
Q1 		$1.68M Buy
+137,322
New +$2.56M 0.01% 1038

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Steve Schonfeld's BBNX Position: Q2 2026 in Review

Steve Schonfeld sold out of Beta Bionics (BBNX) in Q2 2026, closing a stake of 59,624 shares — an estimated $597K sold.

Steve Schonfeld first reported a position in BBNX in Q1 2025 and held it in 4 quarters. The position peaked at $3.65M in Q3 2025. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Steve Schonfeld reported no remaining Beta Bionics position as of Q2 2026 after selling out during the quarter.
  • Steve Schonfeld sold 59,624 Beta Bionics shares in Q2 2026, an estimated $597K.
  • Steve Schonfeld first reported a position in Beta Bionics in Q1 2025 and held it in 4 quarters.
  • Steve Schonfeld's Beta Bionics position peaked at $3.65M in Q3 2025.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.